NBE Therapeutics develops innovative antibody-drug conjugates for oncology treatments, aiming to improve the survival and quality of life for cancer patients worldwide. This includes the creation of targeted medicines with a long-lasting immune oncology effect.
competitor of
Metrics
marketPRIVATE
msh_idCOM:NBE-THERAPEUTICS
localech
websitehttps://nbe-therapeutics.com
source_ref4ed2e520-fe08-4fb8-90d5-a51cde1bc1c4
products_or_servicesAntibody-drug conjugates for oncology, cancer treatment development.
Switzerland